Desensitization And Antiasthmatic Decoction In The Treatment Of Acute Attack Stage Of Bronchial Asthma Clinical Study Of Wind Asthma

Objective:To explore the theory of wind asthma syndrome in the attack stage of bronchial asthma,and to observe the clinical efficacy and safety of "desensitization and antiasthmatic Decoction" as the intervention method,so as to inherit and innovate the academic thought of famous traditional Chinese medicine,and provide some reference opinions for the future clinical diagnosis and treatment and guarantee the further clinical application of the prescription.Methods:From December 2018 to December 2019,60 patients who met the inclusion criteria were selected as the study objects,and randomly divided into treatment group and control group,each group accounted for 30 cases.The control group was given basic antispasmodic and antiasthmatic treatment: inhaled budesonide fomterol powder(xinbico 160ug: 4.5ug),inhaled bid,and orally administered Montecristo tablet(shunerning)10mg QN.The treatment group was treated with desensitization and antiasthmatic Decoction on the basis of the control group.The total course of treatment was 14 days.Finally,statistical data and spss25.0 software were used to analyze and compare the symptom scores,EOS and FEV1 of the two groups before and after the treatment.At the same time,the efficiency of the two groups after the treatment was compared to observe the clinical efficacy and safety of "desensitization Pingchuan Decoction".Results:1.Basic situation: there was no significant difference between the two groups in gender,age,course of disease,severity(P > 0.05).2.Effective rate of TCM syndrome: calculated by the total score of TCM symptoms,the effective rate was 96.7% in the treatment group and 80.0% in the control group,with significant difference(P < 0.05),and the effective rate of TCM syndrome in the treatment group was significantly higher than that in the controlgroup.3.Symptom score of traditional Chinese medicine: there was no significant difference between the two groups before treatment(P > 0.05),with comparability;after treatment,there was a significant difference between the two groups(P < 0.05);after treatment,there was a significant difference between the two groups(P < 0.05),and the treatment group was more able to improve patients than the control group Symptoms.4.Serum index: after treatment,EOS in the two groups decreased,the difference was statistically significant(P < 0.05),and the difference between the two groups was statistically significant(P < 0.05),indicating that the therapeutic effect of the treatment group was better than that of the control group.5.Pulmonary function index: after treatment,the FEV1 value of the two groups increased,and there was a significant difference between the two groups(P < 0.05);there was a significant difference between the two groups after treatment(P < 0.05),suggesting that the treatment group can better improve the pulmonary ventilation than the control group.6.There were no significant adverse events and side effects in the two groups.Conclusion:Desensitization and antiasthmatic decoction can improve the clinical symptoms,reduce airway inflammation,allergy index and improve lung function of patients with asthma at the attack stage(wind asthma syndrome).The combination of Chinese and Western medicine has obvious advantages in improving the efficiency of traditional Chinese medicine syndrome compared with western medicine alone,and it is safe and worth popularizing.